NewsRoom Articles - Page 222 of 606

TuesdayDec 14, 2021 1:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Participates in the Benzinga Global Small Cap Conference; Committed to Innovation and Improving Quality of Life

Lexaria presented at this year’s Benzinga Global Small Cap Conference held on December 8-9, 2021 The event came right after the company announced human clinical hypertension study HYPER-H21-4, its most ambitious one yet Lexaria plans to sublicense its patented DehydraTECH(TM) technology worldwide, allowing for more people to benefit from it Going into 2022, the company looks forward to reporting on results from its HYPER-H21-3 clinical study and receiving Independent Review Board (“IRB”) approval for its HYPER-H21-4 study Lexaria Bioscience (NASDAQ: LEXX) just participated in this year’s Benzinga Global Small Cap Conference. The two-day event was a showcase for small cap…

TuesdayDec 14, 2021 4:20 am

420 with CNW — California Starts Process to Standardize Marijuana Testing

Regulators in the state of California have begun to standardize marijuana testing as mandated by a new law in the state. The objective of this is to eliminate inconsistencies observed in operational cannabis laboratories in the state. Advocates believe that the law will improve reliability and quality as well as discourage laboratory shopping and other practices that produce inauthentic test results. Officials involved in the industry claim that some cannabis businesses look for labs that will produce the results they’d like to see with regard to contaminants and THC potency. Critics also assert that the absence of standards is also…

MondayDec 13, 2021 4:20 pm

420 with CNW — Hemp or Cannabis: Does the CBD Source Matter?

The past few years have seen cannabidiol (“CBD”) grow from an obscure product that was only known to niche consumers to a worldwide phenomenon worth billions of dollars. This was partly thanks to the 2018 farm bill, which legalized industrial hemp and its derivatives after decades of prohibition, and partly to growing reports of CBD’s medical potential. Despite cannabidiol’s growing popularity, however, plenty of people don’t actually know what CBD is or where it comes from. CBD is one of more than 100 chemical compounds that are produced by the cannabis plant called cannabinoids. What we call industrial hemp is…

MondayDec 13, 2021 4:20 am

420 with CNW — Having the Marijuana Munchies? Here’s Why

Cannabis has grown in popularity as more states legalize the herb for recreational and/or medical use. The herb can be consumed in different ways, with the most common methods being through edibles and smoking. Most users usually like to have access to their favorite snacks or meals for consumption after a successful smoking session. This is mainly because of the munchies. While the term munchies is familiar to most, not many know why munchies occur. Today, we look at a couple of factors that can be used to explain why you get munchies after consuming cannabis. Did you know that…

FridayDec 10, 2021 4:20 pm

420 with CNW — Scientists Uncover Cause of Cannabis’ Distinctive Odor

Cannabis has a rich, distinctive odor that’s hard to forget. While plenty of cannabis consumers, especially recreational users, enjoy the skunk-like odor, many users do not. It can be extremely pungent, sticks to clothing and can be hard to get rid of. This makes it difficult to consume either recreational or medical cannabis flower in densely populated communities such as high-rise apartments without affecting others. Now, a new study carried out by a team of California scientists has uncovered the chemical compounds responsible for marijuana’s characteristic aroma. Previous studies on marijuana’s odor looked mostly at terpenes, which are aromatic compounds…

FridayDec 10, 2021 1:19 pm

Don’t Miss NCIA’s 7th Annual Cannabis Business Summit & Expo

Date: December 15-17, 2021 Venue: Moscone Center, San Francisco, California NCIA’s 7th Annual Cannabis Business Summit & Expo will be held in the Moscone Center in San Francisco, California, on December 15-17, 2021. Hosted by the National Cannabis Industry Association ("NCIA"), the largest and oldest national trade association advancing the interests of the legal cannabis industry, the three-day event showcases cannabis industry professionals and advocates Troy Datcher, Calvin Johnson, Jr., Rachael Rapinoe, Anna Symonds, and Marvin Washington as keynote speakers. Key Points: Leading a new generation of c-suite innovators, Chief Executive Officer Troy Datcher, together with Chief Visionary Officer Shawn…

FridayDec 10, 2021 10:47 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Upcoming R&D Programs Targeting Global Markets Totaling Over $160 Billion

Lexaria Bioscience plans to launch approximately 12 applied research and development programs in 2022 The programs are designed to explore the ability of the company’s patented DehydraTECH(TM) to improve drug delivery processes for multiple indications Research will continue into the use of DehydraTECH-CBD for high blood pressure, as well as the technology’s potential for oral nicotine delivery Diabetes, rheumatoid disease, Alzheimer’s Disease, and estrogen delivery, are some of the multiple indications that drug delivery platform innovator Lexaria Bioscience (NASDAQ: LEXX) is planning to target with its research and development programs next year. The markets targeted provide multiple opportunities for success…

FridayDec 10, 2021 4:20 am

420 with CNW — Think Tank Asks White House to Resolve DEA, HHS Cannabis Review Feud

Dozens of states may have legalized medical marijuana, but the federal government still classifies cannabis as a Schedule I Controlled Substance with no known medical applications. For years, two federal agencies have clashed over which of them should determine marijuana’s medical potential by running an independent, peer-reviewed study on the potential health benefits of cannabis consumption. With no end to the disagreement in sight, a libertarian think tank has sent a letter to the White House Office of Management and Budget (“OMB”) asking it to clear the issue. As it stands, the scientific literature used to deny petitions to reschedule…

ThursdayDec 09, 2021 4:20 pm

420 with CNW — Why You Should Start Using CBD Skincare Products

In the recent years, we’ve seen interest in CBD increase greatly, especially since the 2018 Agricultural Improvement Act was passed. CBD (cannabidiol) is one of the two most common active ingredients in cannabis, with the other being THC. CBD does not induce a high by itself, unlike THC, which is a psychoactive compound. The health benefits of CBD have made the compound popular in many industries, the beauty industry among them. CBD skincare products have as a result grown in popularity, with companies producing everything from CBD lotions and soaps to oils. If you’re curious about the products and would…

ThursdayDec 09, 2021 2:02 pm

Flora Growth Corp. (NASDAQ: FLGC) Launches European and Mexican Exports of CBD Skincare Brands

Colombian cannabis cultivator and international wellness product builder Flora Growth Corp. is building a global pipeline for its wide array of branded CBD and medicinal cannabis products The company recently announced that it has begun fulfilling the first orders for its Mind Naturals and Awe CBD skincare brands with exports to Spain and Mexico outlets this month Flora Growth cultivates cannabis at its 100-hectare (247-acre) property in central Colombia Flora also has a GMP certified 16,000-square-foot manufacturing facility in Bogota that produces nearly 200 products for the CBD derivatives and medical cannabis markets Cannabis cultivator and worldwide cannabidiol (“CBD”) brand…